AIFF (AIFF) Stock Price & Analysis
AIFF (AIFF) rose 2.73% to USD 1.13 as of September 8, 2026 at 05:00 UTC, according to Nexqual real-time market data.
AIFF last closed at USD 1.13; the session ranged USD 1.08–1.13 on volume of 48,802 shares. Market capitalization is —, with a 52-week range of USD 0.62–3.15 (NCM). Source: Nexqual, September 8, 2026 at 05:00 UTC.
Key Statistics (as of September 8, 2026 at 05:00 UTC)
| Price | USD 1.13 |
|---|---|
| Change | ▲ 2.73% (up) |
| Previous Close | USD 1.13 |
| Open | USD 1.13 |
| Day Range | USD 1.08 – 1.13 |
| 52-Week Range | USD 0.62 – 3.15 |
| Volume | 48,802 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (AIFF)
Nexqual's technical model rates AIFF "NEUTRAL" based on 2 bullish and 3 bearish signals across 128 daily candles, as of September 8, 2026 at 05:00 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 53.18 (neutral) |
| vs SMA50 | Below (USD 1.14) |
| MACD | -0.02 (negative) |
From AIFF's Latest SEC 10-K Filing (filed 2026-03-31)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| JTAI | Jet.AI Inc. | USD 1.25 | ▼ 2.34% |
| TNON | Tenon Medical, Inc. | USD 3.72 | ▼ 16.78% |
| VTAK | Catheter Precision, Inc. | USD 0.21 | ▲ 5% |
| ATPC | Agape ATP Corporation | USD 2.39 | ▲ 3.46% |
| BDRX | Biodexa Pharmaceuticals plc | USD 0.85 | ▲ 8.03% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 05:00 UTC. This page is informational and not investment advice.